David R. Cameron

5.9k total citations · 1 hit paper
53 papers, 2.4k citations indexed

About

David R. Cameron is a scholar working on Molecular Biology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, David R. Cameron has authored 53 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Infectious Diseases and 10 papers in Molecular Medicine. Recurrent topics in David R. Cameron's work include Antimicrobial Resistance in Staphylococcus (17 papers), Bacterial biofilms and quorum sensing (16 papers) and Antibiotic Resistance in Bacteria (10 papers). David R. Cameron is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (17 papers), Bacterial biofilms and quorum sensing (16 papers) and Antibiotic Resistance in Bacteria (10 papers). David R. Cameron collaborates with scholars based in Switzerland, Australia and United States. David R. Cameron's co-authors include Anton Y. Peleg, David G. Cooper, Stephen D. Krasner, Patricia Chilton, Thomas Risse, Matthew Evangelista, Peter J. Katzenstein, Cal Clark, Thomas Princen and Benjamin P. Howden and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular Cell and PLoS ONE.

In The Last Decade

David R. Cameron

53 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bringing Transnational Relations Back In

1995 506 citations Thomas Risse, David R. Cameron et al. Cambridge University Press eBooks profile →

Peers

Countries citing papers authored by David R. Cameron

Since Specialization

Citations

This map shows the geographic impact of David R. Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Cameron more than expected).

Fields of papers citing papers by David R. Cameron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Cameron. The network helps show where David R. Cameron may publish in the future.

Co-authorship network of co-authors of David R. Cameron

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Cameron. A scholar is included among the top collaborators of David R. Cameron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Cameron. David R. Cameron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting Chronic Biofilm Infections With Patient-derived Phages: An In Vitro and Ex Vivo Proof-of-concept Study in Patients With Left Ventricular Assist Devices 2025 ·Open Forum Infectious Diseases ·Melissa Pitton, (unknown), Simone Oberhaensli, (unknown), (unknown), Parham Sendi, Monika Fürholz, David R. Cameron, Yok‐Ai Que	1
2	BET-inhibitor DYB-41 reduces pulmonary inflammation and local and systemic cytokine levels in LPS-induced acute respiratory distress syndrome: an experimental rodent study 2024 ·Intensive Care Medicine Experimental ·Manuela Iten, (unknown), (unknown), David R. Cameron, Christine Goepfert, David Berger, Matthias Hænggi	1
3	Dynamics of bacterial pathogens at the driveline exit site in patients with ventricular assist devices: A prospective, observational, single-center cohort study 2023 ·The Journal of Heart and Lung Transplantation ·Melissa Pitton, (unknown), Simone Oberhaensli, Carlo Casanova, Parham Sendi, (unknown), Stephan M. Jakob, David R. Cameron, Yok‐Ai Que, Monika Fürholz	3
4	Ten‐year retrospective cohort analysis of ventricular assist device infections 2022 ·Artificial Organs ·(unknown), (unknown), Laura N. Walti, Maks Mihalj, David R. Cameron, Michele Martinelli, Monika Fürholz, Yok‐Ai Que, Chris Hayward, David Reineke, Lukas Hunziker, (unknown)	2
5	Searching for synergy: combining systemic daptomycin treatment with localised phage therapy for the treatment of experimental pneumonia due to MRSA 2021 ·BMC Research Notes ·(unknown), (unknown), Manuela Iten, Denis Grandgirard, Stephen L. Leib, Stephan M. Jakob, Matthias Hænggi, David R. Cameron, Yok‐Ai Que, J Prazák	18
6	Bacterial persisters in long-term infection: Emergence and fitness in a complex host environment 2020 ·PLoS Pathogens ·Jennifer Bartell, David R. Cameron, Biljana Mojsoska, Janus A. J. Haagensen, Tacjana Pressler, Lea M. Sommer, Kim Lewis, Søren Molin, Helle Krogh Johansen	55
7	Hyperosmotic Infusion and Oxidized Surfaces Are Essential for Biofilm Formation of Staphylococcus capitis From the Neonatal Intensive Care Unit 2020 ·Frontiers in Microbiology ·Yue Qu, Yali Li, David R. Cameron, Christopher D. Easton, (unknown), (unknown), Mario Salwiczek, Benjamin W. Muir, Helmut Thissen, Andrew J. Daley, John S. Forsythe, Anton Y. Peleg, Trevor Lithgow	13
8	Antibiotic resistance and host immune evasion in Staphylococcus aureus mediated by a metabolic adaptation 2019 ·Proceedings of the National Academy of Sciences ·Jhih‐Hang Jiang, Md Saruar Bhuiyan, Hsin‐Hui Shen, David R. Cameron, Thusitha Rupasinghe, (unknown), Anton P. Le Brun, Xenia Kostoulias, Cármen Domene, Alex J. Fulcher, Malcolm J. McConville, Benjamin P. Howden, Graham J. Lieschke, Anton Y. Peleg	77
9	Bacteriophages Improve Outcomes in Experimental Staphylococcus aureus Ventilator-associated Pneumonia 2019 ·American Journal of Respiratory and Critical Care Medicine ·J Prazák, Manuela Iten, David R. Cameron, (unknown), Denis Grandgirard, Grégory Resch, Christine Goepfert, Stephen L. Leib, Jukka Takala, Stephan M. Jakob, Yok‐Ai Que, Matthias Hænggi	60
10	Vancomycin susceptibility in methicillin-resistant Staphylococcus aureus is mediated by YycHI activation of the WalRK essential two-component regulatory system 2016 ·Scientific Reports ·David R. Cameron, Jhih‐Hang Jiang, Xenia Kostoulias, (unknown), Anton Y. Peleg	39
11	Identification of a Class of Protein ADP-Ribosylating Sirtuins in Microbial Pathogens 2015 ·Molecular Cell ·J.G.M. Rack, Rosa Morra, Eva Barkauskaite, Rolf Kraehenbuehl, A. Ariza, Yue Qu, Mary Ortmayer, Orsolya Leidecker, David R. Cameron, Ivan Matić, Anton Y. Peleg, David Leys, Ana Traven, Ivan Ahel	76
12	Antibiotic regimen based on population analysis of residing persister cells eradicates Staphylococcus epidermidis biofilms 2015 ·Scientific Reports ·(unknown), Iain D. Hay, David R. Cameron, Mary Speir, Bintao Cui, Feifei Su, Anton Y. Peleg, Trevor Lithgow, Margaret Deighton, Yue Qu	34
13	Impact of daptomycin resistance onStaphylococcus aureusvirulence 2015 ·Virulence ·David R. Cameron, Lawrence I. Mortin, Aileen Rubio, Eleftherios Mylonakis, Robert C. Moellering, George M. Eliopoulos, Anton Y. Peleg	33
14	The RpoB H481Y Rifampicin Resistance Mutation and an Active Stringent Response Reduce Virulence and Increase Resistance to Innate Immune Responses in Staphylococcus aureus 2012 ·The Journal of Infectious Diseases ·Wei Gao, David R. Cameron, John K. Davies, Xenia Kostoulias, (unknown), Kellie L. Tuck, Michael R. Yeaman, Anton Y. Peleg, Timothy P. Stinear, Benjamin P. Howden	78
15	Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus 2012 ·PLoS ONE ·Anton Y. Peleg, Spiros Miyakis, Doyle V. Ward, Ashlee M. Earl, Aileen Rubio, David R. Cameron, Satish K. Pillai, Robert C. Moellering, George M. Eliopoulos	192
16	Serine/Threonine Phosphatase Stp1 Contributes to Reduced Susceptibility to Vancomycin and Virulence in Staphylococcus aureus 2012 ·The Journal of Infectious Diseases ·David R. Cameron, Doyle V. Ward, Xenia Kostoulias, Benjamin P. Howden, Robert C. Moellering, George M. Eliopoulos, Anton Y. Peleg	85
17	The Interface Between Antibiotic Resistance and Virulence in Staphylococcus aureus and Its Impact Upon Clinical Outcomes 2011 ·Clinical Infectious Diseases ·David R. Cameron, Benjamin P. Howden, Anton Y. Peleg	63
18	Comparison of industrial yeast strains for fermentation of spent sulphite pulping liquor fortified with wood hydrolysate 1997 ·Journal of Industrial Microbiology & Biotechnology ·(unknown), David R. Cameron, Sheldon J.B. Duff	10
19	Induction of desiccation tolerance by osmotic treatment in Saccharomyces uvarum var. carlsbergensis 1997 ·Canadian Journal of Microbiology ·Elis C. A. Eleuthério, (unknown), Marcos D. Pereira, (unknown), (unknown), David R. Cameron	15
20	Bringing Transnational Relations Back In breakdown → 1995 ·Cambridge University Press eBooks ·Thomas Risse, David R. Cameron, Peter J. Katzenstein, Cal Clark, Matthew Evangelista, Patricia Chilton, Thomas Princen, Stephen D. Krasner	506

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact